HIV infection and abuse of central nervous system (CNS)
stimulants are both associated with brain damage and
dysfunction. CNS stimulant overdose can lead to microinfarction,
hemorrhagic lesions, and vasculitis (Bostwick, 1981; Cahill
et al., 1981), and may impact frontostriatal systems. Investigations
of HIV-infected (HIV+) individuals have demonstrated deficits
in attention, speed of information processing, motor functioning,
executive functioning, and learning efficiency. These deficits
are consistent with frontostriatal involvement (Heaton
et al., 1995; Martin, 1994). Given the rise in AIDS cases
attributable to drug use at a time when the number of AIDS
cases due to sexual transmission is stable or declining,
it is critical to determine if drug use, especially CNS
stimulants, potentiates HIV-related neuronal injury.